Sanofi
Selection marker for cell transfection and protein production

Last updated:

Abstract:

The present invention is within the field of industrial protein production. The invention provides a novel expression system using dehydroorotate dehydrogenase (DHODH) as a selection marker in combination with leflunomide or a metabolite thereof, notably for use in mammalian cell lines. Expression vectors encoding DHODH, cell lines comprising said vectors and methods of producing recombinant proteins are also provided.

Status:
Grant
Type:

Utility

Filling date:

26 Dec 2019

Issue date:

12 Jul 2022